Business Description
Kmpharmaceutical Co Ltd
ISIN : KR7225430008
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | -9.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.34 | |||||
Beneish M-Score | -2.94 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.1 | |||||
3-Year EBITDA Growth Rate | -26.5 | |||||
3-Year Book Growth Rate | -4.5 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.5 | |||||
9-Day RSI | 56.43 | |||||
14-Day RSI | 52.2 | |||||
6-1 Month Momentum % | -8.68 | |||||
12-1 Month Momentum % | -26.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.63 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 83.3 | |||||
Days Sales Outstanding | 45.95 | |||||
Days Payable | 29.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.33 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 26.16 | |||||
Operating Margin % | -22.09 | |||||
Net Margin % | -25.08 | |||||
FCF Margin % | -8.61 | |||||
ROE % | -10.55 | |||||
ROA % | -7.33 | |||||
ROIC % | -6.26 | |||||
ROC (Joel Greenblatt) % | -11.21 | |||||
ROCE % | -7.16 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.29 | |||||
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 0.58 | |||||
EV-to-EBIT | -11.42 | |||||
EV-to-EBITDA | -22.01 | |||||
EV-to-Revenue | 2.21 | |||||
EV-to-FCF | -24.53 | |||||
Earnings Yield (Greenblatt) % | -8.76 | |||||
FCF Yield % | -6.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kmpharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 14,545.452 | ||
EPS (TTM) (â‚©) | -131 | ||
Beta | 0.58 | ||
Volatility % | 24.12 | ||
14-Day RSI | 52.2 | ||
14-Day ATR (â‚©) | 32.808861 | ||
20-Day SMA (â‚©) | 666.35 | ||
12-1 Month Momentum % | -26.89 | ||
52-Week Range (â‚©) | 599 - 1148 | ||
Shares Outstanding (Mil) | 27.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kmpharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kmpharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kmpharmaceutical Co Ltd Frequently Asked Questions
What is Kmpharmaceutical Co Ltd(XKRX:225430)'s stock price today?
When is next earnings date of Kmpharmaceutical Co Ltd(XKRX:225430)?
Does Kmpharmaceutical Co Ltd(XKRX:225430) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |